HAE · Haemonetics Corp

$82.54 +2.63 (+3.29%) At close · Jul 28

Market Cap

$3.75B

45.45M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2026

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Simon	CEO	$1,100,008	—	$7,561,987	$1,504,968	$1,834,250	$43,488	$12,044,701
James D'Arecca	CFO	$603,698	—	$1,841,481	$499,989	$648,858	$28,990	$3,623,016
Michelle L. Basil	General Counsel	$558,776	—	$1,749,291	$474,983	$599,766	$26,727	$3,409,543
Frank W. Chan	COO	$518,263	$350,000	$1,473,137	$399,998	$574,060	$21,391	$3,336,849
Roy Galvin	Executive Vice President, Chief Commercial Officer	$550,205	—	$1,473,137	$399,998	$586,960	$28,818	$3,039,118

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Simon	CEO	$1,100,000	—	$7,026,668	$1,399,974	$1,131,625	$64,221	$10,722,488
James D'Arecca	CFO	$575,582	—	$1,563,677	$424,958	$381,872	$29,580	$2,975,669
Michelle L. Basil	General Counsel	$537,870	—	$1,471,617	$399,999	$356,242	$28,715	$2,794,443
Roy Galvin	Executive Vice President, Chief Commercial Officer	$490,154	—	$1,011,733	$274,986	$378,263	$41,204	$2,196,340
Stewart Strong	President, Global Hospital Business	$476,702	—	$1,011,733	$274,986	$132,120	$39,162	$1,934,703

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Simon	CEO	$1,088,469	—	$6,320,923	$1,624,959	$2,447,500	$63,262	$11,545,113
James D'Arecca	CFO	$548,213	—	$1,458,507	$374,975	$735,919	$28,445	$3,146,059
Michelle L. Basil	General Counsel	$517,194	—	$1,458,507	$374,975	$694,550	$26,177	$3,071,403
Anila Lingamneni	CTO	$485,070	—	$1,166,831	$299,996	$564,909	$25,611	$2,542,417
Josep L. Llorens	Executive Vice President, Global Manufacturing and Supply Chain	$488,700	—	$1,069,593	$274,977	$568,550	$27,190	$2,429,010

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Simon	CEO	$1,012,885	—	$5,924,933	$1,499,980	$2,200,000	$48,597	$10,686,395
James D'Arecca	CFO	$525,000	$400,000	$1,386,179	$574,980	$770,192	$108,299	$3,764,650
Michelle L. Basil	General Counsel	$498,576	—	$1,382,412	$349,998	$740,411	$19,005	$2,990,402
Josep L. Llorens	Executive Vice President, Global Manufacturing and Supply Chain	$474,923	—	$987,437	$249,984	$608,400	$23,917	$2,344,661
Anila Lingamneni	CTO	$467,430	—	$987,437	$249,984	$598,801	$22,668	$2,326,320
William Burke	CFO	$167,731	$272,490	—	—	$99,664	$10,735	$550,620

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Simon	CEO	$945,000	—	$5,319,246	$1,499,986	$908,523	$29,465	$8,702,220
William Burke	CFO	$543,150	—	$2,329,703	$374,991	$333,419	$18,166	$3,599,429
Michelle L. Basil	General Counsel	$477,619	—	$2,241,162	$349,982	$293,193	$17,778	$3,379,734
Stewart Strong	President, Global Hospital Business	$410,615	—	$1,374,966	$187,485	$489,992	$17,419	$2,480,477
Josep L. Llorens	Executive Vice President, Global Manufacturing and Supply Chain	$440,794	—	$1,109,106	$199,990	$255,645	$22,320	$2,027,855
Anila Lingamneni	CTO	$441,412	—	$1,109,106	$199,990	$251,611	$21,413	$2,023,532
James D'Arecca	CFO	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Simon	CEO	$963,173	—	$5,096,181	$1,499,979	$1,038,461	$27,600	$8,625,394
William Burke	CFO	$539,283	—	$1,104,204	$324,983	$370,005	$16,573	$2,355,048
Michelle L. Basil	General Counsel	$474,204	—	$1,019,211	$299,996	$325,364	$16,137	$2,134,912
Anila Lingamneni	CTO	$434,962	$100,000	$649,518	$349,991	$276,963	$33,403	$1,844,837
Josep L. Llorens	Executive Vice President, Global Manufacturing and Supply Chain	$413,714	—	$594,371	$174,970	$267,632	$19,406	$1,470,093

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Simon	CEO	$937,211	—	$5,493,885	$1,374,979	$1,563,408	$28,721	$9,398,204
William Burke	CFO	$525,164	—	$1,198,495	$299,979	$557,045	$17,529	$2,598,212
Michelle L. Basil	General Counsel	$461,803	—	$1,298,603	$274,990	$489,838	$17,209	$2,542,443
Josep L. Llorens	Executive Vice President, Global Manufacturing and Supply Chain	$404,020	—	$599,247	$149,990	$402,921	$19,949	$1,576,127
Jacqueline D. Scanlan	Senior Vice President, Global Human Resources	$406,457	—	$599,247	$149,990	$369,541	$16,097	$1,541,332

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Simon	CEO	$893,954	—	$4,586,629	$1,062,485	$1,980,000	$27,742	$8,550,810
William Burke	CFO	$501,292	—	$841,217	$243,744	$708,853	$17,188	$2,312,294
Michelle L. Basil	General Counsel	$440,811	—	$862,844	$249,997	$578,807	$16,387	$2,148,846
Jacqueline D. Scanlan	Senior Vice President, Global Human Resources	$387,981	—	$474,516	$137,477	$470,250	$15,350	$1,485,574

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Simon	CEO	$858,462	—	$4,396,692	$1,062,497	$1,399,830	$133,829	$7,851,310
Michelle L. Basil	General Counsel	$425,818	$150,000	$822,699	$249,999	$411,321	$22,371	$2,082,208
William Burke	CFO	$482,328	—	$765,142	$232,494	$506,735	$18,049	$2,004,748
Jacqueline D. Scanlan	Senior Vice President, Global Human Resources	$375,000	$100,000	$386,638	$117,497	$301,688	$138,327	$1,419,149

Executive changes

Person	Role	Change	Effective	Filed
Martin Madaus	director	Appointed	2026-07-24	2026-07-28

Key facts CIK 313143 CUSIP 405024100 13F (30d) 66 filings 66 filers Visit website Investor relations